Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-17

Clinical Trial Update: Famciclovir in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for famciclovir in multiple sclerosis is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famciclovir (famciclovir)

Snippet

Sponsor: Queen Mary University of London | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN